Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?

被引：0
|
作者：
Liu, Jinan
Thaker, Premal H.
Sah, Janvi
Maiese, Eric M.
Bee, Oscar
Hurteau, Jean
Chan, John
机构：
[1] GlaxoSmithKline, Navy Yard, PA USA
[2] Washington Univ, Sch Med, Dept Gynecol Oncol, St Louis, MO 63110 USA
[3] STATinMED Res, Ann Arbor, MI USA
[4] GlaxoSmithKline, Waltham, MA USA
[5] Palo Alto Med Fdn, Calif Pacific, Sutter Hlth, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 28期
关键词：
D O I：
10.1200/JCO.2020.39.28_suppl.294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
294
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer
    Salani, Ritu
    Boyle, Tirza Areli Calderon
    Lim, Jonathan
    Schilder, Jeanne M.
    Hurteau, Jean A.
    Perhanidis, Jessica
    Golembesky, Amanda
    Backes, Floor J.
    FUTURE ONCOLOGY, 2025, 21 (02) : 213 - 219
  • [12] Real-world experience with a first-line niraparib maintenance monotherapy for advanced ovarian carcinoma
    Gregoric, Brigita
    Skof, Erik
    Skrbinc, Breda
    Geltar, Ana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A220 - A220
  • [13] The real-world use of first-line maintenance treatment regimens among patients with advanced ovarian cancer varies by biomarker status: results from the Europa study
    Fagotti, Anna
    Braicu, Elena
    Frenel, Jean-Sebastien
    Saint-Ghislain, Mathilde
    Wirtz, Marina
    Lim, Jonathan
    Boyle, Tirza
    Mascialino, Barbara
    Arnold, Kellyn
    Chaparova, Elena
    Hogg, Catherine
    Golembesky, Amanda
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A211 - A212
  • [14] Outcomes of niraparib first-line maintenance among patients with BRCA wild-type advanced ovarian cancer in a real-world clinical setting
    Kupets, Rachel
    Piedimonte, Sabrina
    Clarfield, Lauren
    Manley, Mollie
    Peragine, Christine
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S265 - S266
  • [15] Patterns in maintenance therapy use in advanced ovarian cancer patients: Real-world data analysis
    Taylor, Sarah
    Gart, Michael
    Choksi, Rushir
    Thomas, Roby
    Katzen, Harvey
    Donegan, Janet
    Vasudevan, Anupama
    Alwon, Erin
    Varughese, Prateesh
    Blanc, Simon
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S333 - S333
  • [16] Real-world progression-free survival among patients with newly diagnosed advanced ovarian cancer: Does maintenance therapy work?
    Liu, Jinan
    Chan, John
    Sah, Janvi
    Maiese, Eric M.
    Bee, Oscar
    Hurteau, Jean
    Thaker, Premal H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [17] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE USE, AND COSTS BY LINE OF THERAPY AMONG NEWLY DIAGNOSED ENDOMETRIAL CANCER PATIENTS
    Nwankwo, Chizoba
    Shah, Ruchitbhai
    Kebede, Nehemiah
    Shah, Anuj
    Corman, Shelby
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A33 - A34
  • [18] Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Ogando, Yoscar M.
    Verma, Rishi P.
    Grall, Veronique
    Marth, Christian
    FUTURE ONCOLOGY, 2024,
  • [19] Real-world experience with a first-line olaparib maintenance monotherapy for advanced BRCA mutated ovarian carcinoma
    Skof, Erik
    Gregoric, Brigita
    Skrbinc, Breda
    Jansa, Vid
    Cvjeticanin, Branko
    Krajec, Maja
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A305 - A305
  • [20] MEDx HRDetectCDx predicts the response of newly diagnosed advanced ovarian cancer patients in china to first-line maintenance treatment with niraparib
    Zuo, Jing
    Wang, Ke
    Cui, Zhumei
    Zhang, Hui
    Li, Qingshui
    Wang, Shuhe
    Sun, Lixin
    Zhang, Jun
    Zheng, Min
    Zhao, Hongqin
    Chen, Xiaoxiang
    Cheng, Xiaodong
    Hong, Li
    Gao, Yang
    Song, Wenhui
    Wang, Yu
    Zhao, Jiaxing
    Jiang, Zeyu
    Zhang, Yafei
    Wu, Lingying
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A316 - A316
12345